Lymphoma is one of the most common malignancies in dogs, usually presenting as a painless swelling of the peripheral lymph nodes. However, diagnosis can be complex due to lymphoid proliferation in internal organs. The recently launched SENSITEST cLBT assay is designed to offer objective and precise assessment of canine lymphoma, assisting in both initial diagnosis and remission monitoring. This high sensitivity assay requires just 2 ml of whole blood, and can detect lymphoma up to 8 weeks before physical symptoms emerge, offering greater prognostic insight than palpation techniques.
Avacta will also be showcasing its new SENSITEST canine environmental screen on the stand. Based on the same ELISA technology as the Company’s existing allergy tests, this new laboratory service offers uses four mixed allergy panels –weeds, trees, grasses and household allergens – to provide an economical and convenient initial assessment as a precursor to immunotherapy treatment.
To learn more, visit Avacta Animal Health on Stand 1003
About Avacta Animal Health
Avacta Animal Health provides laboratory services and revolutionary in-clinic testing solutions to veterinary practices worldwide. Our SENSITEST® range of serological allergy tests assist in the diagnosis of allergies in cats, dogs and horses, and we have recently launched a unique canine lymphoma blood test (cLBT) to provide a new tool to assist vets in the diagnosis and remission monitoring of canine lymphoma.
Avacta Animal Health is an ISO 9001 2008 registered company.